BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34083104)

  • 1. Sources of Missing Sexual Orientation and Gender Identity Data in the Behavioral Risk Factor Surveillance System.
    Jesdale BM
    Am J Prev Med; 2021 Aug; 61(2):281-290. PubMed ID: 34083104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will Veterans Answer Sexual Orientation and Gender Identity Questions?
    Ruben MA; Blosnich JR; Dichter ME; Luscri L; Shipherd JC
    Med Care; 2017 Sep; 55 Suppl 9 Suppl 2():S85-S89. PubMed ID: 28806370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contextual Influences on Nonresponse to Health Survey Questions About Sexual Orientation and Gender Identity.
    Zhang ZM; Smith-Johnson M; Tumin D
    LGBT Health; 2024 Jan; 11(1):66-73. PubMed ID: 37582286
    [No Abstract]   [Full Text] [Related]  

  • 4. Refusal Rates to Sexual Orientation and Gender Identity Items in the Behavioral Risk Factor Surveillance System, 2014-2019.
    O'Brien RP; Blosnich JR
    Am J Public Health; 2022 Mar; 112(3):443-452. PubMed ID: 35196048
    [No Abstract]   [Full Text] [Related]  

  • 5. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
    Charkhchi P; Schabath MB; Carlos RC
    J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Sexual Orientation and Lifetime Prevalence of Skin Cancer in the United States.
    Singer S; Tkachenko E; Hartman RI; Mostaghimi A
    JAMA Dermatol; 2020 Apr; 156(4):441-445. PubMed ID: 32049301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Disparities Among Sexual and Gender Minorities With Adverse Childhood Experiences: Insights From the 2021 Behavioral Risk Factor Surveillance System Data.
    Solberg MA; Blair LM; Schlegel EC; Kurzer JAMJ
    Am J Public Health; 2023 Dec; 113(12):1343-1351. PubMed ID: 37939340
    [No Abstract]   [Full Text] [Related]  

  • 8. Measuring Sexual and Gender Minority Populations in Health Surveillance.
    Patterson JG; Jabson JM; Bowen DJ
    LGBT Health; 2017 Apr; 4(2):82-105. PubMed ID: 28287877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Social Determinants of Health Among Sexual Minority Women and Men in 2017.
    Downing JM; Rosenthal E
    Am J Prev Med; 2020 Jul; 59(1):118-122. PubMed ID: 32201187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual and gender minority cigarette smoking disparities: An analysis of 2016 Behavioral Risk Factor Surveillance System data.
    Hoffman L; Delahanty J; Johnson SE; Zhao X
    Prev Med; 2018 Aug; 113():109-115. PubMed ID: 29763683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine collection of sexual orientation and gender identity data: a mixed-methods study.
    Pinto AD; Aratangy T; Abramovich A; Devotta K; Nisenbaum R; Wang R; Kiran T
    CMAJ; 2019 Jan; 191(3):E63-E68. PubMed ID: 30665975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoping review of the structuring of questions about sexual orientation and gender identity.
    Young SK; Bond MA
    J Community Psychol; 2023 Sep; 51(7):2592-2617. PubMed ID: 37088990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual Orientation and Gender Identity Data Completeness at US Federally Qualified Health Centers, 2020 and 2021.
    Liu M; King D; Mayer KH; Grasso C; Keuroghlian AS
    Am J Public Health; 2023 Aug; 113(8):883-892. PubMed ID: 37319390
    [No Abstract]   [Full Text] [Related]  

  • 14. If They Don't Count Us, We Don't Count: Trump Administration Rolls Back Sexual Orientation and Gender Identity Data Collection.
    Cahill SR; Makadon HJ
    LGBT Health; 2017 Jun; 4(3):171-173. PubMed ID: 28453387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adults' willingness to report sexual orientation and gender identity when registering for a digital health application: A cross-sectional quantitative study.
    Marshall J; Zhang X; Green BB
    PLoS One; 2023; 18(11):e0292739. PubMed ID: 37983232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of Sexual Orientation and Gender Identity in Stage 3 Meaningful Use Guidelines: A Huge Step Forward for LGBT Health.
    Cahill SR; Baker K; Deutsch MB; Keatley J; Makadon HJ
    LGBT Health; 2016 Apr; 3(2):100-2. PubMed ID: 26698386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explanation of Errors in Population Numbers and Missing Data in Studies of Lifetime Skin Cancer Associated With Sexual Orientation and Gender Identity.
    Singer S; Tkachenko E; Hartman RI; Mostaghimi A
    JAMA Dermatol; 2020 Jul; 156(7):822-823. PubMed ID: 32492083
    [No Abstract]   [Full Text] [Related]  

  • 18. Sexual Orientation Identity, Race/Ethnicity, and Lifetime HIV Testing in a National Probability Sample of U.S. Women and Men: An Intersectional Approach.
    Agénor M; Pérez AE; Koma JW; Abrams JA; McGregor AJ; Ojikutu BO
    LGBT Health; 2019; 6(6):306-318. PubMed ID: 31314667
    [No Abstract]   [Full Text] [Related]  

  • 19. Face Validity Ratings of Sexual Orientation Scales by Sexual Minority Adults: Effects of Sexual Orientation and Gender Identity.
    Galupo MP; Mitchell RC; Davis KS
    Arch Sex Behav; 2018 May; 47(4):1241-1250. PubMed ID: 28733825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing "Something Else" as a Sexual Identity: Evaluating Response Options on the National Health Interview Survey.
    Eliason MJ; Streed CG
    LGBT Health; 2017 Oct; 4(5):376-379. PubMed ID: 28561636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.